Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity

Journal of Molecular Neuroscience - United States
doi 10.1007/s12031-015-0517-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Author Correction: Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis

Scientific Reports
Multidisciplinary
2019English

Low Serum Paraoxonase1 Activity Levels Predict Coronary Artery Disease Severity

Oncotarget
Oncology
2016English

Serum Osteoprotegerin as a Biomarker for Vascular Disease

American Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Pulmonary Clearance of Vasoactive Intestinal Peptide.

Thorax
PulmonaryRespiratory Medicine
1986English

Inhalation of Vasoactive Intestinal Peptide in Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Serum Activin B Levels as Predictive Biomarker for Ectopic Pregnancy

Canadian Journal of Biotechnology
2017English

Gait Variability as Digital Biomarker of Disease Severity in Huntington’s Disease

Journal of Neurology
Neurology
2020English

Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease

Scientific Reports
Multidisciplinary
2015English

Detection of Alpha-Synuclein Conformational Variants From Gastro-Intestinal Biopsy Tissue as a Potential Biomarker for Parkinson's Disease

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy